Beyond metabolic messengers: Bile acids and TGR5 as pharmacotherapeutic intervention for psychiatric disorders

Psychiatric disorders pose a significant global health challenge, exacerbated by the COVID-19 pandemic and insufficiently addressed by the current treatments. This review explores the emerging role of bile acids and the TGR5 receptor in the pathophysiology of psychiatric conditions, emphasizing thei...

Full description

Saved in:
Bibliographic Details
Main Authors: Arief Gunawan Darmanto, Ting-Lin Yen, Jing-Shiun Jan, Tran Thanh Duy Linh, Rajeev Taliyan, Chih-Hao Yang, Joen-Rong Sheu
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Pharmacological Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661824005097
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841553848386191360
author Arief Gunawan Darmanto
Ting-Lin Yen
Jing-Shiun Jan
Tran Thanh Duy Linh
Rajeev Taliyan
Chih-Hao Yang
Joen-Rong Sheu
author_facet Arief Gunawan Darmanto
Ting-Lin Yen
Jing-Shiun Jan
Tran Thanh Duy Linh
Rajeev Taliyan
Chih-Hao Yang
Joen-Rong Sheu
author_sort Arief Gunawan Darmanto
collection DOAJ
description Psychiatric disorders pose a significant global health challenge, exacerbated by the COVID-19 pandemic and insufficiently addressed by the current treatments. This review explores the emerging role of bile acids and the TGR5 receptor in the pathophysiology of psychiatric conditions, emphasizing their signaling within the gut-brain axis. We detail the synthesis and systemic functions of bile acids, their transformation by gut microbiota, and their impact across various neuropsychiatric disorders, including major depressive disorder, general anxiety disorder, schizophrenia, autism spectrum disorder, and bipolar disorder. The review highlights how dysbiosis and altered bile acid metabolism contribute to the development and exacerbation of these neuropsychiatric disorders through mechanisms involving inflammation, oxidative stress, and neurotransmitter dysregulation. Importantly, we detail both pharmacological and non-pharmacological interventions that modulate TGR5 signaling, offering potential breakthroughs in treatment strategies. These include dietary adjustments to enhance beneficial bile acids production and the use of specific TGR5 agonists that have shown promise in preclinical and clinical settings for their regulatory effects on critical pathways such as cAMP-PKA, NRF2-mediated antioxidant responses, and neuroinflammation. By integrating findings from the dynamics of gut microbiota, bile acids metabolism, and TGR5 receptor related signaling events, this review underscores cutting-edge therapeutic approaches poised to revolutionize the management and treatment of psychiatric disorders.
format Article
id doaj-art-cbb100f271984e2392889bf7e7f880ca
institution Kabale University
issn 1096-1186
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Pharmacological Research
spelling doaj-art-cbb100f271984e2392889bf7e7f880ca2025-01-09T06:13:07ZengElsevierPharmacological Research1096-11862025-01-01211107564Beyond metabolic messengers: Bile acids and TGR5 as pharmacotherapeutic intervention for psychiatric disordersArief Gunawan Darmanto0Ting-Lin Yen1Jing-Shiun Jan2Tran Thanh Duy Linh3Rajeev Taliyan4Chih-Hao Yang5Joen-Rong Sheu6Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan, ROC; School of Medicine, Universitas Ciputra, Surabaya 60219, IndonesiaDepartment of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan, ROC; Department of Medical Research, Cathay General Hospital, Taipei 22174, Taiwan, ROCDepartment of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan, ROCFamily Medicine Training Center, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 700000, Viet NamNeuropsychopharmacology Division, Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Pilani Campus, Pilani, Rajasthan, IndiaDepartment of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan, ROC; Research Center for Neuroscience, Taipei Medical University, Taipei, Taiwan, ROC; Corresponding author at: Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan, ROC.Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan, ROC; Research Center for Neuroscience, Taipei Medical University, Taipei, Taiwan, ROC; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan, ROC; Corresponding author at: Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan, ROC.Psychiatric disorders pose a significant global health challenge, exacerbated by the COVID-19 pandemic and insufficiently addressed by the current treatments. This review explores the emerging role of bile acids and the TGR5 receptor in the pathophysiology of psychiatric conditions, emphasizing their signaling within the gut-brain axis. We detail the synthesis and systemic functions of bile acids, their transformation by gut microbiota, and their impact across various neuropsychiatric disorders, including major depressive disorder, general anxiety disorder, schizophrenia, autism spectrum disorder, and bipolar disorder. The review highlights how dysbiosis and altered bile acid metabolism contribute to the development and exacerbation of these neuropsychiatric disorders through mechanisms involving inflammation, oxidative stress, and neurotransmitter dysregulation. Importantly, we detail both pharmacological and non-pharmacological interventions that modulate TGR5 signaling, offering potential breakthroughs in treatment strategies. These include dietary adjustments to enhance beneficial bile acids production and the use of specific TGR5 agonists that have shown promise in preclinical and clinical settings for their regulatory effects on critical pathways such as cAMP-PKA, NRF2-mediated antioxidant responses, and neuroinflammation. By integrating findings from the dynamics of gut microbiota, bile acids metabolism, and TGR5 receptor related signaling events, this review underscores cutting-edge therapeutic approaches poised to revolutionize the management and treatment of psychiatric disorders.http://www.sciencedirect.com/science/article/pii/S1043661824005097Bile AcidsTGR5 ReceptorPsychiatric DisordersGut-Brain AxisPharmacological Interventions
spellingShingle Arief Gunawan Darmanto
Ting-Lin Yen
Jing-Shiun Jan
Tran Thanh Duy Linh
Rajeev Taliyan
Chih-Hao Yang
Joen-Rong Sheu
Beyond metabolic messengers: Bile acids and TGR5 as pharmacotherapeutic intervention for psychiatric disorders
Pharmacological Research
Bile Acids
TGR5 Receptor
Psychiatric Disorders
Gut-Brain Axis
Pharmacological Interventions
title Beyond metabolic messengers: Bile acids and TGR5 as pharmacotherapeutic intervention for psychiatric disorders
title_full Beyond metabolic messengers: Bile acids and TGR5 as pharmacotherapeutic intervention for psychiatric disorders
title_fullStr Beyond metabolic messengers: Bile acids and TGR5 as pharmacotherapeutic intervention for psychiatric disorders
title_full_unstemmed Beyond metabolic messengers: Bile acids and TGR5 as pharmacotherapeutic intervention for psychiatric disorders
title_short Beyond metabolic messengers: Bile acids and TGR5 as pharmacotherapeutic intervention for psychiatric disorders
title_sort beyond metabolic messengers bile acids and tgr5 as pharmacotherapeutic intervention for psychiatric disorders
topic Bile Acids
TGR5 Receptor
Psychiatric Disorders
Gut-Brain Axis
Pharmacological Interventions
url http://www.sciencedirect.com/science/article/pii/S1043661824005097
work_keys_str_mv AT ariefgunawandarmanto beyondmetabolicmessengersbileacidsandtgr5aspharmacotherapeuticinterventionforpsychiatricdisorders
AT tinglinyen beyondmetabolicmessengersbileacidsandtgr5aspharmacotherapeuticinterventionforpsychiatricdisorders
AT jingshiunjan beyondmetabolicmessengersbileacidsandtgr5aspharmacotherapeuticinterventionforpsychiatricdisorders
AT tranthanhduylinh beyondmetabolicmessengersbileacidsandtgr5aspharmacotherapeuticinterventionforpsychiatricdisorders
AT rajeevtaliyan beyondmetabolicmessengersbileacidsandtgr5aspharmacotherapeuticinterventionforpsychiatricdisorders
AT chihhaoyang beyondmetabolicmessengersbileacidsandtgr5aspharmacotherapeuticinterventionforpsychiatricdisorders
AT joenrongsheu beyondmetabolicmessengersbileacidsandtgr5aspharmacotherapeuticinterventionforpsychiatricdisorders